TrialLeukemia2015

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.

E Clappier et al.PubMed ↗Publisher ↗

No numbers read from the abstract.